在印度北部,Clostridioides difficile超级感染是与中度至重度性结肠炎相关的急性发作的主要致病因素吗?
Hitesh Panchal1, Sukrit Sud1, Rajesh Puri1
1Department of Gastroenterology, Medanta - The Medicity, Sector 38, Islampur, Gurgaon, 122 102, India.
概括
在性结肠炎发作中,硬性菌感染不常见,在本研究中患病率为2.9%. 抗生素暴露并没有显著增加风险,患者在标准治疗下恢复良好.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 临床医学 临床医学
背景情况:
- 性结肠炎 (UC) 的爆发可能源于疾病进展或外部因素.
- 克洛斯特里迪奥伊德困难感染和细胞巨乳病毒 (CMV) 大肠炎是造成阴性UC爆发的重要原因.
- 在UC爆发中评估C. difficile的流行率对于患者管理至关重要.
研究的目的:
- 为了确定中度至重度性结肠炎爆发的患者中Clostridioides difficile感染的患病率.
- 调查先前抗生素暴露与UC爆发中的C. difficile感染之间的关联.
主要方法:
- 在印度一家三级医疗中心对140名患有急性发作的UC患者进行前性研究.
- 在入院前8周内评估抗生素暴露.
- 使用酶相关免疫吸收试验 (ELISA) 进行同时进行谷氨酸脱酶 (GDH) 和C. difficile毒素测试.
主要成果:
- 困难菌感染的总体患病率为2.9% (140名患者中有4名).
- 50%的感染患者最近接触过抗生素.
- 这四名患者都通过口服万科米辛和美特罗尼达获得了无事件的康复.
结论:
- 在这个三级护理中心,C. difficile感染不是中度至重度性结肠炎爆发的主要驱动因素.
- 研究结果表明,C. difficile在这种特定患者群体中对UC恶化有很小的贡献.
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Ulcerative Colitis in IBD
589
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
589
Chronic Bowel Disorders: Introduction
871
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
871
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
998
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
998
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
593
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
593


